November 13, 2012

Voices of IP: Peter Bradley, Innate Immunotherapeutics


Revolutionary Treatments from New Technology
Peter Bradley, Chief Business Development Officer
Auckland, New Zealand

Innate Immunotherapeutics Limited and its 8 employees are dedicated to designing and manufacturing a unique immunomodulator microparticle technology. This technology helps people with multiple sclerosis, cancers and various infectious diseases. Bradley sates that “intellectual property is pivotal” to the development of this technology and to taking their invention to the market and being able to get a return to their investors.

www.IPdelivers.com

  OUR LATEST ON TWITTER

Global Innovation Policy Center @globalIPcenter 6h

All 50 states are home to clinical trials for #COVID19 solutions. Explore your state’s innovation footprint with our interactive map. https://t.co/viWBKFlnE5 https://t.co/viWBKFlnE5

Reply Retweet Favorite


Subscribe for updates from GIPC